Hey Sabbath.
As DT has previously stated, and I paraphrase; If there is a material development with the Ellume contract it will be announced, its not information that can be held onto and announced to suit an agenda and there are a number of directors who will ensure this...IMO.
It has been mentioned ad nauseum a new collaborator would mean a material change to the product that has received FDA approval and that whole process will have to be redone. That's not going to happen.
Id suggest your post is nothing more than fearmongering....
Ellume, page-80
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 247857 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable